
Five Consecutive Losses Push Indo US Bio-Tech Ltd to a New 52-Week Low
2026-06-03 15:36:29For the fifth straight session, Indo US Bio-Tech Ltd closed lower, breaching its 52-week low at Rs 94 on 3 Jun 2026, marking a 6.42% decline over the last three days and underperforming its sector by 2.46% today alone.
Read full news article
Indo US Bio-Tech Q4 FY26: Margin Compression and Profit Decline Signal Operational Challenges
2026-05-30 23:54:33Indo US Bio-Tech Ltd., a micro-cap agricultural products company with a market capitalisation of ₹201.00 crores, reported a challenging fourth quarter for FY26, with net profit declining sharply to ₹1.97 crores from ₹3.00 crores in Q3 FY26, marking a 34.33% sequential decline. On a year-on-year basis, the profit contraction was even steeper at 46.47% compared to ₹3.68 crores in Q4 FY25. The stock, currently trading at ₹100.45, has struggled significantly over the past year, declining 41.45% whilst the broader market fell just 8.40%, underscoring deep investor concerns about the company's operational trajectory.
Read full news article
Indo US Bio-Tech Ltd is Rated Sell
2026-05-29 10:10:22Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market performance.
Read full news article
Indo US Bio-Tech Ltd is Rated Sell
2026-05-18 10:10:16Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Indo US Bio-Tech Ltd is Rated Sell
2026-05-07 10:10:27Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Indo US Bio-Tech Ltd is Rated Sell
2026-04-26 10:10:13Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Indo US Bio-Tech Ltd is Rated Sell
2026-04-15 10:10:17Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 15 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read full news article
Indo US Bio-Tech Ltd is Rated Sell
2026-04-04 10:10:25Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Indo US Bio-Tech Ltd is Rated Sell
2026-03-24 10:10:16Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleCorporate Actions
No Upcoming Board Meetings
Indo US Bio-Tech Ltd has declared 2% dividend, ex-date: 03 Dec 24
No Splits history available
Indo US Bio-Tech Ltd has announced 1:1 bonus issue, ex-date: 29 Aug 23
No Rights history available






